SUMMARY Peripheral blood T cell subsets were measured using monoclonal antibodies and a fluorescence activated cell sorter in 15 untreated patients with Lambert-Eaton myasthenic syndrome (nine with small cell carcinoma, one undifferentiated epithelial tumour (ca-LEMS)), five with no demonstrable tumour (non-ca-LEMS), 10 age-matched healthy controls and 10 patients with small cell carcinoma without neurological disease. OKT8+ (suppressor/cytotoxic) T non-carcinomatous forms is established by the finding that its physiological features and the characteristic changes in presynaptic active zone particles can be induced in mice by daily injections of the IgG fraction of LEMS plasma.' [9] [10][11] 
The Lambert-Eaton myasthenic syndrome (LEMS) is now considered to be an autoimmune disorder, mediated by IgG autoantibodies to determinants concerned with acetylcholine release at the motor nerve terminal. ' The disease is characterised by proximal muscle weakness2 and autonomic disturbance.3 Two thirds of cases are associated with carcinoma, usually of the small cell type, and almost half have organ specific autoantibodies.4 Physiological5 and pharmacological6 studies on biopsied LEMS muscle have shown a reduction in the number of quanta of acetylcholine released from the nerve terminal, with consequent reduction in the amplitude of the evoked muscle action potential. Nonquantal release of transmitter ("molecular leakage") is also reduced.6 Freeze fracture studies have shown loss and disorganisation of presynaptic active zone particles, which may represent calcium channels. ' Plasma exchange causes a transient improvement in LEMS symptoms and immunosuppressive drug treatment in the non-carcinomatous cases leads to improvement or recovery.8 The immunological nature of disease in both its carcinomatous and non-carcinomatous forms is established by the finding that its physiological features and the characteristic changes in presynaptic active zone particles can be induced in mice by daily injections of the IgG fraction of LEMS plasma.' [9] [10] [11] The mechanism of induction of the disease is unknown. It has been suggested that autoimmunity arises when there is a disturbance in the balance between inducer and suppressor subsets within the human T cell circuit. '2 We therefore studied the distribution of peripheral blood T cell subsets, using monoclonal antibodies and a fluorescence activated cell sorter, in patients with recently diagnosed and untreated LEMS, both in its carcinomatous and non-carcinomatous form. 
